Fundraising Fox
Graeme Martin
InvestorVenture Partner at ALSA Ventures · Executive Chairman at Pro Matix
United Kingdom
Find your path to Graeme
316 people in our graph can introduce you to Graeme.
Each arrow is one introduction. Sign up to fill in the first one.
Ask Arjun Mehra to introduce you to Graeme
You →Arjun · together at Harrington Discovery Institute at University Hospitals (2019) →Graeme
Ask Jamie Chen to introduce you to Graeme
You →Jamie · 2 people · together at Montis Biosciences →Graeme
Ask Sam Okafor to introduce you to Graeme
You →Sam · 2 people · together at Vantage Biosciences →Graeme
Sign up to find every way you can get introduced to Graeme
- Your email: the people you already email who know Graeme
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Graeme
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
About
Graeme has a forty-year career in pharma and biotech across Europe, the USA and Japan, with senior R&D roles at Roche, GSK and Wellcome, and served as President and CEO of Takeda Ventures. He holds a BSc and PhD in Pharmacology.
Executive Chairman at Pro Matix
Intro paths
In turn, Graeme can intro founders to Pro Matix's investors below.
Pro Matix's investors · 1
Experience
- Promatix Biosciences LtdExecutive Chairpersoncurrent2025 — present
- Promatix Biosciences LtdNon Executive Directorcurrent2024 — present
- Vantage BiosciencesNon Executive Directorcurrent2024 — present
- ALSA VenturesBoard Member / Consultantcurrent2024 — presentLondon Area, United Kingdom
- ALSA VenturesChief Investment Officer2019 — 2024London, England, United Kingdom
- BioNeexMember Of The Board Of Advisorscurrent2022 — present
- Montis BiosciencesNon Executive Directorcurrent2022 — present
- Harrington Discovery Institute at University HospitalsHarrington Discovery Institute Investment Advisorcurrent2019 — presentCleveland, Ohio, United States
- ARJUNA TherapeuticsNon Executive Directorcurrent2018 — presentLondon, England, United Kingdom
- HatchBox Bioconsulting LLCPrincipalcurrent2017 — presentBay Area, CA, USA
- DJS AntibodiesChairperson2018 — 2022Oxford, England, United Kingdom
- Scioto Biosciences, IncNon Executive Director2018 — 2020Indianapolis, Indiana, United States
- 3Brain AGNon Executive Director2017 — 2019Wädenswil, Zurich, Switzerland
- Takeda Ventures, Inc.President & CEO2003 — 2017Palo Alto, CA, USA
- RocheVice President, CNS Therapeutic Area1996 — 2001Palo Alto, CA, USA
Skills & more
+8 more
CommercializationRegulatory AffairsStrategic PartnershipsStrategic ThinkingStrategic ConsultingBusiness StrategyCancer TherapeuticsTherapeutic ModalitiesFrom Graeme's professional profile.
Investments
Investor
ArmaGen TechnologiesHeptares TherapeuticsLectus TherapeuticsNaurexPresage BiosciencesRedwood BioscienceSerenexSymphogenUnivercells’s website
Per curated public sources.
Colleagues at ALSA Ventures
Frequently asked questions
- Who is Graeme Martin?
- Graeme has a forty-year career in pharma and biotech across Europe, the USA and Japan, with senior R&D roles at Roche, GSK and Wellcome, and served as President and CEO of Takeda Ventures. He holds a BSc and PhD in Pharmacology.
- Where does Graeme Martin work?
- Graeme Martin is Venture Partner at ALSA Ventures and Executive Chairman at Pro Matix.
- What companies has Graeme Martin invested in?
- Investments tracked here include ArmaGen Technologies, Heptares Therapeutics, Lectus Therapeutics, Naurex, Presage Biosciences, Redwood Bioscience, Serenex, Symphogen, Univercells’s website.
- Where did Graeme Martin go to school?
- Graeme Martin studied at UCL (Ph.D., Pharmacology); University of Bath (B.Sc., Pharmacology); UCL (Ph.D., Pharmacology).
Same school
Also attended UCL704
+ 698 more
Also attended University of Bath221
+ 215 more
Shared employers
Also worked at ALSA Ventures7
+ 1 more
